Design, synthesis, spectroscopic characterizations, antidiabetic, in silico and kinetic evaluation of novel curcumin-fused aldohexoses.
Blood glucose
Curcumin
Diabetes mellitus
Hyperglycemia
α-Amylase
α-Glucosidase
Journal
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
ISSN: 1873-3557
Titre abrégé: Spectrochim Acta A Mol Biomol Spectrosc
Pays: England
ID NLM: 9602533
Informations de publication
Date de publication:
15 Jan 2023
15 Jan 2023
Historique:
received:
10
05
2022
revised:
21
08
2022
accepted:
27
08
2022
pubmed:
16
9
2022
medline:
16
11
2022
entrez:
15
9
2022
Statut:
ppublish
Résumé
Curcumin (bis-α,β-unsaturated β-diketone) plays an important role in the prevention of numerous diseases, including diabetes. Curcumin, as an enzyme inhibitor, has ideal structural properties including hydrophobic nature, flexible backbone, and several available hydrogen bond (H-bond) donors and acceptors. In this study, curcumin-fused aldohexose derivatives 3(a-c) were synthesized and used as influential agents in the treatment of diabetes with inhibitory properties against two carbohydrate-hydrolyzing enzymes α-glucosidase (α-Gls) and α-amylase (α-Amy) which are known to be significant therapeutic targets for the reduction of postprandial hyperglycemia. These compounds were isolated, purified, and then spectrally characterized via FT-IR, Mass,
Identifiants
pubmed: 36108405
pii: S1386-1425(22)00954-4
doi: 10.1016/j.saa.2022.121806
pii:
doi:
Substances chimiques
Hypoglycemic Agents
0
Curcumin
IT942ZTH98
alpha-Glucosidases
EC 3.2.1.20
alpha-Amylases
EC 3.2.1.1
Glycoside Hydrolase Inhibitors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
121806Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.